Attending ASCO 2026?
Don't go in blind. Get our curated networking cheatsheet with party lists & investor maps.
Join 5,000+ Life Science Leaders
Official Registration
Visit Official Website ↗Strategic Context
ASCO Annual Meeting is the world's leading oncology conference, presenting the latest groundbreaking research and clinical trial data across all cancer types. Attendees gain access to thousands of abstracts, expert-led educational sessions, and opportunities to engage with global oncology leaders. It is an essential event for staying current with advances in cancer treatment, diagnostics, and patient care.
Who Attends
Oncologists, Clinical Researchers, HCPs, Cancer Biologists, Pharmacologists, Patient Advocates
Accommodation for ASCO 2026 typically sells out 3–4 months in advance. We recommend booking hotels near the venue immediately after registration opens.
Coverage from ASCO 2026
Few Pediatric Cancer Drugs Reach Phase 3 or Approval
The pipeline for pediatric oncology drugs remains sparse, with most candidates failing to progress beyond early-phase trials to approval.
Early Breast Cancer at ASCO 2026: Trials to Watch
ASCO 2026 is expected to bring pivotal data on adjuvant and neoadjuvant strategies in early breast cancer. Here is what clinicians should watch for.